Enveric Biosciences (ENVB) Return on Assets [ROA] (2011 - 2026)
Enveric Biosciences' Return on Assets [ROA] came in at -120.69% for Q2 2026, up 109.19 percentage points from -229.88% a year earlier and up 34.16 percentage points from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Enveric Biosciences' Return on Assets [ROA] was -214.51%, up 44.89 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of +111.93 percentage points (FY2020 to FY2025).
- Going back by year, Return on Assets [ROA] was -259.40% in FY2024 (-114.41 pp), -144.99% in FY2023 (-65.15 pp), -79.84% in FY2022 (+238.03 pp) and -317.87% in FY2021 (+8.58 pp).
- The Q2 2026 figure represents the highest quarterly Return on Assets [ROA] since Q4 2022.
- Year-over-year, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of +34.20 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q3 2024 (a gain of 110.76 percentage points), and the weakest in Q4 2023 (a drop of 228.84 percentage points).
- Business Quant data shows ENVB's Return on Assets [ROA] at -154.85% (Q1 2026), -185.49% (Q4 2025) and -246.06% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | -120.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -120.69% |
| Mar 31, 2026 | -154.85% |
| Dec 31, 2025 | -185.49% |
| Sep 30, 2025 | -246.06% |
| Jun 30, 2025 | -229.88% |
| Mar 31, 2025 | -227.33% |
| Dec 31, 2024 | -243.24% |
| Sep 30, 2024 | -181.82% |
| Jun 30, 2024 | -142.19% |
| Mar 31, 2024 | -229.22% |
| Dec 31, 2023 | -316.73% |
| Sep 30, 2023 | -292.58% |
| Jun 30, 2023 | -184.59% |
| Mar 31, 2023 | -124.43% |
| Dec 31, 2022 | -87.88% |
| Sep 30, 2022 | -211.92% |
| Jun 30, 2022 | -210.72% |
| Mar 31, 2022 | -212.80% |
| Dec 31, 2021 | -133.99% |
| Sep 30, 2021 | -34.69% |
API Access
Enveric Biosciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();